Active substanceSalicylic acid + Zinc oxideSalicylic acid + Zinc oxide
Similar drugsTo uncover
Dosage form: & nbsppowder for external use
Composition:

Ingredients per 100 g:

Active substances:

Salicylic acid - 2 g

Zinc oxide - 10 g

Excipients:

Talc - 44 g

Potato starch - 44 g.

Description:The powder is white or greyish-white, greasy to the touch.
Pharmacotherapeutic group:Antiseptic
ATX: & nbsp

D.08.A.X   Other antiseptics and disinfectants

Pharmacodynamics:

Combined drug for external use. Salicylic acid has anti-inflammatory, antiseptic and keratolytic effects. Zinc oxide has a drying effect.

Indications:

Subacute eczema of various genesis, hyperhidrosis (sweating) of feet.

Contraindications:

Hypersensitivity to the components of the drug, children under 12 years.

Pregnancy and lactation:

In pregnancy and during breastfeeding apply only if the intended benefit to the mother exceeds the potential risk to the fetus and the baby. Before using Halmanin, if you are pregnant, or suspect that you might be pregnant, or plan a pregnancy, you should consult your doctor.

Dosing and Administration:

Outwardly. In the form of a powder, a thin layer of powder is applied to the affected areas of the skin and clean (washed with soap and wiped dry) skin once a day.

If there is no improvement after treatment, or the symptoms worsen, or new symptoms appear, it is necessary to consult a doctor.

Use the drug only according to the indications, the method of administration and the doses specified in the instructions for use.

Side effects:

Allergic reactions, local reactions - itching, burning.If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

Overdose:

So far, no cases of overdose have been reported.

Interaction:

Interaction with other drugs has not been studied.

Effect on the ability to drive transp. cf. and fur:

The use of the drug does not affect the performance of potentially hazardous activities requiring special attention and quick reactions (vehicle management, working with moving mechanisms, dispatcher and operator work).

Form release / dosage:

Powder for external use.

Packaging:

By 2 g, 5 g, 10 g, 20 g and 25 g in heat-sealing bags of packaging combined material; material combined "Buflen" or laminated paper. By 3, 5, 10, 12, 20, 25 or 30 packets together with the instruction for use are placed in a pack of cardboard.

By 20 g, 30 g, 40 g and 50 g in cans of high or low pressure polyethylene complete with lids or in cans of polyethylene terephthalate with the means of corking.

Each bank along with the instruction for use is placed in a pack of cardboard.The full text of the instructions for use should be applied to the pack.

50, 100, 200, 400 packages without a bundle, together with an equal number of instructions for use, are placed in a carton box (for hospitals).

For 30 or 40 cans without a bundle, together with an equal number of instructions for use are placed in a cardboard box (for hospitals).

Storage conditions:

In a dry, protected from light place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life:

5 years. Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe
Registration number:LP-004532
Date of registration:13.11.2017
Expiration Date:13.11.2022
The owner of the registration certificate:IVANOVSKAYA Pharmaceutical Factory, OAO IVANOVSKAYA Pharmaceutical Factory, OAO Russia
Manufacturer: & nbsp
Information update date: & nbsp05.12.2017
Illustrated instructions
    Instructions
    Up